PNLIP and hepatocellular carcinoma: Altogether, these data indicated that self-renewal ability is more effectively inhibited by ATO co-treated with PTL in HCC cell lines, suggesting that PTL may eliminate the cancer stem cells to exert the effect of ATO-mediated anti-tumor.